OSCR OSCAR HEALTH INC - CLASS A
Consumer, Non-cyclical · Healthcare-Services
Lean: bullishOSCR sentiment is clearly bullish, but the strongest voices split between rotation buyers and chart-target traders rather than one clean fundamental thesis. The late-week shift was a broadening from $30 breakout talk into $35-$45 target calls, while some credible holders began trimming into the move. Trade structure looks momentum-led and crowded: upside depends on healthcare/value rotation persisting, while extension risk is now the main near-term check.
Bulls argue OSCR is being rerated as healthcare and value reclaim leadership, with technical breakouts above $30 opening $35-$45 targets. The better-quality support comes from rotation and fundamental-execution framing, while several high-volume target calls come from authors with cold recent trader scores.
Key voicesThe bear case is thin and mostly about exhaustion rather than business impairment: profit-taking after a sharp run, CEO share sales, and unusual puts. This is not a converged bearish camp.
Key voicesTracked hypotheses — caliber-scored view · 2026-06-22
🟢 HIGH caliber (1)
📈 h2 bull · score 0.74
OSCR remains an early-stage long-term compounder despite the run, with bulls targeting $45-$60 over time.
- Supporters (6): @TheRonnieVShow↗(MEDIUM-,5p), @growthrapidly↗(MEDIUM,3p), @cevikfinance↗(MEDIUM-,1p), @StockChaser_↗(MEDIUM,2p), @MMatters22596↗(MEDIUM,1p), +1
- Signals: 13 · Max author share: 0.36 · Novelty: building
- Quote: "Would allocate all fresh capital to OSCR and a few other favored compounders" — TheRonnieVShow
🟡 MEDIUM caliber (4)
📈 h1 bull · score 0.61
OSCR technical breakout, volume expansion, and trend structure point to further upside toward the $40-$55 range.
- Supporters (9): @ChartBreakouts(LOW-MED,1p), @chad_ventures↗(MEDIUM,2p), @TheLongInvest↗(MEDIUM-,2p), @ElliotWaveBull↗(LOW-MED,2p), @TheWaveCount↗(LOW-MED,2p), +4
- Signals: 13 · Max author share: 0.14 · Novelty: stable
- Quote: "New 52-week highs arrived with volume not seen since June 2021" — AlbertAgarunov
📈 h3 bull · score 0.49
Improving revenue growth and profitability execution support OSCR’s business re-rating beyond purely technical momentum.
- Supporters (4): @Ashton_1nvests↗(MEDIUM,2p), @TheRonnieVShow↗(MEDIUM-,1p), @Stevendiaz↗(MEDIUM,1p), @BullTradeFinder↗(MEDIUM-,1p)
- Signals: 5 · Max author share: 0.40 · Novelty: building
- Quote: "Constructive thesis centers on revenue growth and improving profitability execution" — Ashton_1nvests
📈 h4 bull · score 0.47
CEO insider buying is interpreted as validating the OSCR bull case and preceding the stock’s major rally.
- Supporters (6): @MMatters22596↗(MEDIUM,1p), @WealthCode99978↗(MEDIUM,1p), @StockChaser_↗(MEDIUM,1p), @danielisdizzy↗(MEDIUM,2p), @TheRonnieVShow↗(MEDIUM-,1p), +1
- Signals: 7 · Max author share: 0.29 · Novelty: stable
- Quote: "Recent CEO purchases are presented as a bullish signal of management confidence" — WealthCode99978
📈 h5 bull · score 0.32
Capital is rotating toward overlooked healthcare and non-AI growth names, giving OSCR sector-level sponsorship.
- Supporters (5): @TheRonnieVShow↗(MEDIUM-,1p), @MMatters22596↗(MEDIUM,1p), @TTstocks(LOW-MED,1p), @AlphaScout360↗(LOW-MED,1p), @Chartradamus↗(LOW-MED,1p)
- Signals: 7 · Max author share: 0.20 · Novelty: stable
- Quote: "Focused on healthcare and financial names while avoiding semiconductors" — TheRonnieVShow
⚪ LOW caliber (1)
📉 h7 bear · score 0.24
After a 100%-plus rally, OSCR is extended and likely needs a pullback, retest, or profit-taking phase.
- Supporters (5): @cialuTrading↗(MEDIUM,1p), @Arturraposo1R↗(LOW-MED,2p), @TheWaveCount↗(LOW-MED,1p), @TheMarket_Monk↗(LOW-MED,1p), @fundmyfund↗(MEDIUM,1p)
- Signals: 6 · Max author share: 0.33 · Novelty: building
- Quote: "OSCR may need a healthy correction after a 179% impulsive move" — cialuTrading
🔴 FLAGGED caliber (2)
📈 h6 bull · score 0.05
September short-put activity suggests options traders are willing to underwrite OSCR downside at current volatility.
- Supporters (1): @OptionsHawk↗(HIGH,1p)
- Signals: 1 · Max author share: 1.00 · Novelty: stable
- ⚠️ Concentration: 100% from @optionshawk↗ HIGH cred
- Quote: "Large September short-put opening indicates traders are selling downside risk" — OptionsHawk
↔️ h8 neutral · score 0.03
Some holders are trimming OSCR gains and rotating capital into perceived safer or lagging healthcare opportunities.
- Supporters (1): @apex_actuary↗(MEDIUM,2p)
- Signals: 2 · Max author share: 1.00 · Novelty: stable
- ⚠️ Concentration: 100% from @apex_actuary↗ MEDIUM cred
- Quote: "Reallocated OSCR gains into NVO as part of broader small-cap derisking" — apex_actuary
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @TheRonnieVShow | C | -0.15 | 18 | +0.58 |
| @TheLongInvest | C | -2.16 | 17 | +0.49 |
| @growthrapidly | C | -3.00 | 14 | +0.49 |
| @Arturraposo1R | B | -0.45 | 12 | +0.50 |
| @enrichtrades | C | -1.64 | 12 | +0.53 |
| @MMatters22596 | C | +1.15 | 11 | +0.33 |
| @StockChaser_ | C | +2.04 | 9 | +0.47 |
| @fundmyfund | B | -2.01 | 7 | +0.32 |
| @TheStockerMan | B | +3.05 | 7 | +0.52 |
| @TheValueTrade | C | +1.95 | 7 | +0.41 |
| @RealHeel80 | C | +0.53 | 6 | +0.27 |
| @EmmanuelInvest | C | -1.12 | 5 | +0.20 |
| @Ashton_1nvests | B | +1.00 | 5 | +0.53 |
| @TheWaveCount | C | +0.70 | 4 | +0.21 |
| @Stevendiaz | B | +3.67 | 4 | +0.15 |
| @TheEUInvestor | C | -0.74 | 4 | +0.20 |
| @MitchMartan98 | C | +1.40 | 4 | +0.46 |
| @apex_actuary | C | +0.16 | 4 | +0.20 |
| @ChrisLaCoursie1 | C | +0.71 | 4 | +0.13 |
| @BullTradeFinder | C | -0.39 | 4 | +0.29 |
| @cleverhandeln | C | -0.20 | 3 | +0.28 |
| @Venu_7_ | B | -0.45 | 3 | +0.45 |
| @TheMarket_Monk | C | -1.53 | 2 | +0.00 |
| @SeegerErik | C | -1.01 | 2 | +0.05 |
| @TrendSpider | C | -0.58 | 2 | +0.38 |
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-03 | @Apollo_21mil | +0.25 | Says OSCR is almost to target, implying prior chart target nearing completion. | — | tweet ↗ |
| 2026-07-03 | @BullTradeFinder | +0.25 | Still loading more ZETA shares down here. — Author says they are loading more ZETA and compares setup to PLTR. | — | tweet ↗ |
| 2026-07-03 | @BullTradeFinder | +0.30 | Implies ZETA and RIVN may follow OSCR-style move soon. | — | tweet ↗ |
| 2026-07-03 | @Arturraposo1R | +0.50 | Says HIMS, OSCR and NVO are all you need this year. | — | tweet ↗ |
| 2026-07-02 | @TrendSpider | +0.45 | Says OSCR CEO is printing, bullish slang without trade mechanics. | — | tweet ↗ |
| 2026-07-02 | @TheRonnieVShow | +0.65 | Discloses concentrated Roth holding OSCR and ZETA LEAPS with high conviction. | — | tweet ↗ |
| 2026-07-02 | @OpenOutcrier | -0.20 | Recap of unusual put option activity from 7/2. | — | tweet ↗ |
| 2026-07-02 | @derekquick1 | +0.45 | Says health and value have done well and will outperform from here. | — | tweet ↗ |
| 2026-07-02 | @OptionsFlowBoss | +0.40 | Unusual bullish options activity detected in OSCR. | — | tweet ↗ |
| 2026-07-02 | @TheProfInvestor | +0.45 | Calls for positioning in leading healthcare and banks amid rotation. | — | tweet ↗ |
| 2026-07-02 | @InversorNovato_ | +0.45 | Reports prior OSCR system entries returned +63% and +14%. | — | tweet ↗ |
| 2026-07-02 | @EmmanuelInvest | +0.20 | Health insurance stocks mixed with Oscar outperforming and long-term digital health thesis. | — | tweet ↗ |
| 2026-07-02 | @Sir_Kory | +0.45 | Praises CEO and notes company value doubled YTD. | — | tweet ↗ |
| 2026-07-02 | @MoneyNomads1 | +0.55 | Constructive thesis on Oscar Health turnaround to GAAP profitability near $30. | — | tweet ↗ |
| 2026-07-02 | @Nice_Stock_ | +0.15 | Mentions previously studied Oscar Health with watch emoji but no clear stance. | — | tweet ↗ |
| 2026-07-02 | @FlowbyBobby | +0.25 | Reports selling $80K OSCR 27 puts expiring 2026-08-21. | — | tweet ↗ |
| 2026-07-02 | @Arturraposo1R | +0.35 | Portfolio performance post names HIMS and OSCR as ramping quickly. | — | tweet ↗ |
| 2026-07-02 | @Arturraposo1R | +0.55 | Calls for healthcare portfolio to outperform Tech and AI until end of 2026. | — | tweet ↗ |
| 2026-07-02 | @MitchMartan98 | +0.45 | Argues EM and healthcare rotation was coming and cites Druck positioning. | — | tweet ↗ |
| 2026-07-02 | @Arturraposo1R | +0.45 | Describes rotating away from crowded AI winners into next bull-run positions like healthcare and cyclicals. | — | tweet ↗ |
| 2026-07-02 | @apex_actuary | +0.00 | Discloses rotation out of OSCR and PEPE into CELH plus portfolio weights. | — | tweet ↗ |
| 2026-07-02 | @BullTradeFinder | +0.35 | Says AMD and MU exceeded expectations, while OSCR and TSLA are getting there. | — | tweet ↗ |
| 2026-07-02 | @TheLongInvest | +0.35 | Recaps prior support call at 12 and current price 31. | — | tweet ↗ |
| 2026-07-01 | @Stevendiaz | +0.25 | Compares insider buys with subsequent performance and argues insider buying is not guaranteed bullish. | +0.9% | tweet ↗ |
| 2026-07-01 | @TradexWhisperer | +0.65 | Reports OSCR is up 22% since prior shared confirmation and gives bullish drivers. | +0.9% | tweet ↗ |
| 2026-07-01 | @dannycheng2022 | +0.55 | Frames retail hate on named holdings as a contrarian signal increasing conviction. | +0.9% | tweet ↗ |
| 2026-07-01 | @AlexMarenco1 | +0.05 | Daily market note says weak session, tech lag, distribution days, exposure 80-100%. | +0.9% | tweet ↗ |
| 2026-07-01 | @enrichtrades | +0.35 | Watchlist for 7/2; staying focused on leaders and trading small. | +0.9% | tweet ↗ |
| 2026-07-01 | @Mr_Derivatives | +0.25 | Notes OSCR up almost 200% since CEO bought lows in April. | +0.9% | tweet ↗ |
| 2026-07-01 | @ChartWaveInvest | +0.30 | Says OSCR is right on track with chart attached. | +0.9% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.